Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05971173Phase 1Completed
Phase 1, open-label trial in hip fracture (2 arms), sponsored by UT Health San Antonio. Primary endpoint: Assessment of surgical complications at 26 weeks. Started Sep 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05971173.